TREVI THERAPEUTICS, INC.

Analyst Reco. Trevi Therapeutics, Inc.

Equities

TRVI

US89532M1018

Market Closed - Nasdaq Other stock markets 01:30:00 27/04/2024 am IST			5-day change	1st Jan Change
2.78 ^USD	+9.45%		-1.94%	+107.46%

20/03	Transcript : Trevi Therapeutics, Inc., Q4 2023 Earnings Call, Mar 20, 2024
20/03	Trevi Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

B. Riley Starts Trevi Therapeutics at Buy With $6 PT, Views as Deep Value Play in Idiopathic Pulmonary Fibrosis Chronic Cough Space	12/23/12	MT
JonesTrading Initiates Trevi Therapeutics at Buy With $7 Price Target	14/23/14	MT
SVB Securities Starts Trevi Therapeutics at Outperform With $6 Price Target	22/22/22	MT
Oppenheimer Adjusts Trevi Therapeutics Price Target to $9 From $12 Mainly on Higher Discount Rate, Maintains Outperform Rating	15/22/15	MT
Needham Trims Price Target on Trevi Therapeutics to $8 From $10, Maintains Buy Rating	11/22/11	MT
Oppenheimer Adjusts Trevi Therapeutics' Price Target to $12 From $10, Maintains Outperform Rating	30/22/30	MT
Needham Adjusts Trevi Therapeutics' Price Target to $10 From $8, Reiterates Buy Rating	30/22/30	MT
Trevi Therapeutics Rises After Oppenheimer Starts Coverage With Outperform Rating	25/22/25	MT
Oppenheimer Starts Trevi Therapeutics at Outperform With $10 Price Target	25/22/25	MT
Aegis Capital Initiates Trevi Therapeutics at Buy with $10 Price Target	29/22/29	MT
Needham Adjusts Price Target on Trevi Therapeutics to $8 from $10, Keeps Buy Rating	11/21/11	MT
TREVI THERAPEUTICS : Needham Adjusts Trevi Therapeutics' Price Target to $10 from $12, Keeps Buy Rating	13/21/13	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer